TITLE

Sibutramine pulled from market

PUB. DATE
December 2010
SOURCE
Internal Medicine Alert;12/15/2010 Clinical Briefs, p1
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports on the move of Abbott Laboratories Inc. to withdraw its weight-loss drug sibutramine (Meridia) from the market because the U.S. Food and Drug Administration (FDA) found that patients with cardiovascular disease or diabetes given sibutramine had a significantly higher rate of serious cardiovascular events compared to placebo.
ACCESSION #
57803283

 

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics